The innovation unit of Hadassah Cancer Research Center
This Cancer research innovation unit is devoted to translational research in the field of oncology. Harnessing Hadassah’s clinical excellence for cutting edge immuno-oncology research, the unit provides pre-clinical services that include customized in vitro and in vivo assays for the testing of novel anti-cancer therapies.
This unit leverages two outstanding advantages:
- The unit has its own GMP-grade facility for cancer immunotherapy, that is available for certain customer service, e.g. adoptive cell transfer, engineered T cell therapy (TCR)
- As a part of Hadassah Medical Center, the unit has an easy excess to human samples, patient data and clinical insights.